BioAffinity Total Current Assets vs Cash Analysis

BIAFW Stock

USD 0.57 0.13 18.57%

BioAffinity Technologies financial indicator trend analysis is way more than just evaluating BioAffinity Technologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioAffinity Technologies is a good investment. Please check the relationship between BioAffinity Technologies Total Current Assets and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Total Current Assets vs Cash

Total Current Assets vs Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioAffinity Technologies Total Current Assets account and Cash. At this time, the significance of the direction appears to have totally related.

The correlation between BioAffinity Technologies' Total Current Assets and Cash is 1.0. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Cash in the same time period over historical financial statements of bioAffinity Technologies Warrant, assuming nothing else is changed. The correlation between historical values of BioAffinity Technologies' Total Current Assets and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of bioAffinity Technologies Warrant are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Total Current Assets i.e., BioAffinity Technologies' Total Current Assets and Cash go up and down completely randomly.

Correlation Coefficient

1.0

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Cash

Cash refers to the most liquid asset of BioAffinity Technologies, which is listed under current asset account on bioAffinity Technologies Warrant balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from BioAffinity Technologies customers. The amounts must be unrestricted with restricted cash listed in a different BioAffinity Technologies account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Most indicators from BioAffinity Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioAffinity Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

At this time, BioAffinity Technologies' Tax Provision is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 7.1 M in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	1.0M	2.5M	37.1K	35.3K
Depreciation And Amortization	4.8K	10.2K	249.6K	262.1K

Interest Expense Depreciation And Amortization

BioAffinity Technologies fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Long Term Debt	Non Current Liabilities Total	Inventory	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		-0.55	-0.08	-0.51	0.78	0.56	-0.85	-0.8	0.81	0.92	0.53	-0.47	0.92	0.51	-0.54	1.0	0.97	-0.33	0.95	-0.57	0.95	0.81	-0.98	-0.5	0.98	0.56
Short Long Term Debt Total	-0.55		0.81	1.0	-0.95	-0.43	0.86	0.26	-0.27	-0.49	-0.41	0.37	-0.49	-0.4	0.34	-0.53	-0.5	0.93	-0.51	1.0	-0.56	-0.11	0.6	0.81	-0.57	-0.43
Other Current Liab	-0.08	0.81		0.84	-0.61	-0.01	0.53	-0.27	0.2	-0.09	0.0	0.05	-0.09	0.01	0.11	-0.06	0.0	0.91	-0.08	0.78	-0.09	0.45	0.12	0.83	-0.08	0.0
Total Current Liabilities	-0.51	1.0	0.84		-0.93	-0.42	0.83	0.23	-0.24	-0.45	-0.4	0.34	-0.45	-0.39	0.31	-0.48	-0.46	0.94	-0.46	0.99	-0.52	-0.07	0.56	0.82	-0.53	-0.41
Total Stockholder Equity	0.78	-0.95	-0.61	-0.93		0.55	-0.96	-0.52	0.5	0.72	0.52	-0.49	0.72	0.5	-0.5	0.77	0.73	-0.8	0.74	-0.95	0.76	0.4	-0.81	-0.77	0.8	0.55
Property Plant And Equipment Net	0.56	-0.43	-0.01	-0.42	0.55		-0.39	-0.86	0.81	0.28	1.0	0.05	0.28	1.0	-0.05	0.52	0.69	-0.12	0.35	-0.5	0.73	0.61	-0.7	-0.26	0.65	1.0
Net Debt	-0.85	0.86	0.53	0.83	-0.96	-0.39		0.49	-0.47	-0.86	-0.35	0.62	-0.86	-0.33	0.64	-0.85	-0.75	0.73	-0.87	0.86	-0.76	-0.44	0.83	0.75	-0.85	-0.39
Retained Earnings	-0.8	0.26	-0.27	0.23	-0.52	-0.86	0.49		-0.91	-0.63	-0.85	0.22	-0.63	-0.84	0.35	-0.79	-0.87	-0.08	-0.67	0.32	-0.85	-0.87	0.87	0.17	-0.86	-0.87
Accounts Payable	0.81	-0.27	0.2	-0.24	0.5	0.81	-0.47	-0.91		0.55	0.8	0.01	0.55	0.79	-0.07	0.78	0.93	-0.02	0.62	-0.33	0.93	0.89	-0.87	-0.23	0.8	0.81
Cash	0.92	-0.49	-0.09	-0.45	0.72	0.28	-0.86	-0.63	0.55		0.25	-0.7	1.0	0.23	-0.79	0.95	0.81	-0.31	1.0	-0.49	0.77	0.66	-0.85	-0.47	0.91	0.29
Non Current Assets Total	0.53	-0.41	0.0	-0.4	0.52	1.0	-0.35	-0.85	0.8	0.25		0.08	0.25	1.0	-0.02	0.49	0.67	-0.11	0.31	-0.48	0.7	0.59	-0.68	-0.23	0.62	1.0
Non Currrent Assets Other	-0.47	0.37	0.05	0.34	-0.49	0.05	0.62	0.22	0.01	-0.7	0.08		-0.7	0.09	0.82	-0.5	-0.3	0.29	-0.66	0.35	-0.23	-0.31	0.36	0.07	-0.5	0.05
Cash And Short Term Investments	0.92	-0.49	-0.09	-0.45	0.72	0.28	-0.86	-0.63	0.55	1.0	0.25	-0.7		0.23	-0.79	0.95	0.81	-0.31	1.0	-0.49	0.77	0.66	-0.85	-0.47	0.91	0.29
Net Receivables	0.51	-0.4	0.01	-0.39	0.5	1.0	-0.33	-0.84	0.79	0.23	1.0	0.09	0.23		0.0	0.47	0.65	-0.1	0.29	-0.46	0.69	0.59	-0.66	-0.22	0.6	1.0
Common Stock Shares Outstanding	-0.54	0.34	0.11	0.31	-0.5	-0.05	0.64	0.35	-0.07	-0.79	-0.02	0.82	-0.79	0.0		-0.59	-0.36	0.17	-0.74	0.33	-0.31	-0.24	0.48	0.34	-0.63	-0.06
Other Current Assets	1.0	-0.53	-0.06	-0.48	0.77	0.52	-0.85	-0.79	0.78	0.95	0.49	-0.5	0.95	0.47	-0.59		0.95	-0.31	0.97	-0.55	0.93	0.8	-0.97	-0.5	0.98	0.53
Other Stockholder Equity	0.97	-0.5	0.0	-0.46	0.73	0.69	-0.75	-0.87	0.93	0.81	0.67	-0.3	0.81	0.65	-0.36	0.95		-0.26	0.86	-0.54	0.99	0.87	-0.98	-0.44	0.95	0.7
Total Liab	-0.33	0.93	0.91	0.94	-0.8	-0.12	0.73	-0.08	-0.02	-0.31	-0.11	0.29	-0.31	-0.1	0.17	-0.31	-0.26		-0.32	0.91	-0.32	0.12	0.34	0.77	-0.3	-0.12
Total Current Assets	0.95	-0.51	-0.08	-0.46	0.74	0.35	-0.87	-0.67	0.62	1.0	0.31	-0.66	1.0	0.29	-0.74	0.97	0.86	-0.32		-0.52	0.82	0.7	-0.89	-0.48	0.94	0.36
Short Term Debt	-0.57	1.0	0.78	0.99	-0.95	-0.5	0.86	0.32	-0.33	-0.49	-0.48	0.35	-0.49	-0.46	0.33	-0.55	-0.54	0.91	-0.52		-0.6	-0.16	0.63	0.8	-0.6	-0.49
Common Stock	0.95	-0.56	-0.09	-0.52	0.76	0.73	-0.76	-0.85	0.93	0.77	0.7	-0.23	0.77	0.69	-0.31	0.93	0.99	-0.32	0.82	-0.6		0.83	-0.98	-0.51	0.93	0.73
Long Term Debt	0.81	-0.11	0.45	-0.07	0.4	0.61	-0.44	-0.87	0.89	0.66	0.59	-0.31	0.66	0.59	-0.24	0.8	0.87	0.12	0.7	-0.16	0.83		-0.79	0.05	0.78	0.62
Non Current Liabilities Total	-0.98	0.6	0.12	0.56	-0.81	-0.7	0.83	0.87	-0.87	-0.85	-0.68	0.36	-0.85	-0.66	0.48	-0.97	-0.98	0.34	-0.89	0.63	-0.98	-0.79		0.55	-0.98	-0.71
Inventory	-0.5	0.81	0.83	0.82	-0.77	-0.26	0.75	0.17	-0.23	-0.47	-0.23	0.07	-0.47	-0.22	0.34	-0.5	-0.44	0.77	-0.48	0.8	-0.51	0.05	0.55		-0.51	-0.25
Net Invested Capital	0.98	-0.57	-0.08	-0.53	0.8	0.65	-0.85	-0.86	0.8	0.91	0.62	-0.5	0.91	0.6	-0.63	0.98	0.95	-0.3	0.94	-0.6	0.93	0.78	-0.98	-0.51		0.65
Property Plant And Equipment Gross	0.56	-0.43	0.0	-0.41	0.55	1.0	-0.39	-0.87	0.81	0.29	1.0	0.05	0.29	1.0	-0.06	0.53	0.7	-0.12	0.36	-0.49	0.73	0.62	-0.71	-0.25	0.65

Click cells to compare fundamentals

BioAffinity Technologies Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for BioAffinity Stock Analysis

When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioAffinity Total Current Assets vs Cash Analysis

Total Current Assets vs Cash

Total Current Assets vs Cash Correlation Analysis

Correlation Coefficient

Total Current Assets

Cash

BioAffinity Technologies fundamental ratios Correlations

BioAffinity Technologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for BioAffinity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Current Assets	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Short Long Term Debt Total
Short Term Debt	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Net Receivables	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net

Net Invested Capital	- 0.98	Non Current Liabilities Total
Non Current Liabilities Total	- 0.98	Common Stock
Non Current Liabilities Total	- 0.98	Other Stockholder Equity
Non Current Liabilities Total	- 0.98	Total Assets
Non Current Liabilities Total	- 0.97	Other Current Assets
Net Debt	- 0.96	Total Stockholder Equity